Mdetect develops DNA methylation based liquid biopsy technology for detecting and managing metastatic breast cancer.
mDETECT Inc has raised $366K in total funding. The most recent round was Seed. The last funding was announced in May 2026.
mDETECT Inc's investors include Ontario Centre of Innovation.
mDETECT Inc is headquartered in Kingston, Canada.
Mdetect develops DNA methylation based liquid biopsy technology for detecting and managing metastatic breast cancer.
mDETECT Inc is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"mDETECT Inc — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/mdetect-inc. Accessed August 22, 2026.
VCBacked. (2026). mDETECT Inc — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/mdetect-inc
{{cite web |title=mDETECT Inc — Funding & Investors |url=https://www.vcbacked.co/company/mdetect-inc |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated